The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 21, 2025

Filed:

Sep. 06, 2019
Applicant:

Factor Bioscience Inc., Cambridge, MA (US);

Inventors:

Matthew Angel, Cambridge, MA (US);

Christopher Rohde, Cambridge, MA (US);

Assignee:

Factor Bioscience Inc., Cambridge, MA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 48/00 (2006.01); A61B 18/18 (2006.01); A61G 19/00 (2006.01); A61K 8/60 (2006.01); A61K 9/00 (2006.01); A61K 9/127 (2006.01); A61K 31/573 (2006.01); A61K 31/575 (2006.01); A61K 31/7068 (2006.01); A61K 31/7072 (2006.01); A61K 31/7105 (2006.01); A61K 31/711 (2006.01); A61K 31/713 (2006.01); A61K 38/38 (2006.01); A61K 38/39 (2006.01); A61K 38/44 (2006.01); A61K 38/45 (2006.01); A61K 45/06 (2006.01); A61K 47/46 (2006.01); A61Q 19/00 (2006.01); A61Q 19/06 (2006.01); A61Q 19/08 (2006.01); C12N 15/87 (2006.01); C12N 15/90 (2006.01); A61B 18/00 (2006.01);
U.S. Cl.
CPC ...
A61K 38/39 (2013.01); A61B 18/18 (2013.01); A61G 19/00 (2013.01); A61K 8/606 (2013.01); A61K 9/0019 (2013.01); A61K 9/0021 (2013.01); A61K 9/127 (2013.01); A61K 31/573 (2013.01); A61K 31/575 (2013.01); A61K 31/7068 (2013.01); A61K 31/7072 (2013.01); A61K 31/7105 (2013.01); A61K 31/711 (2013.01); A61K 31/713 (2013.01); A61K 38/38 (2013.01); A61K 38/44 (2013.01); A61K 38/45 (2013.01); A61K 45/06 (2013.01); A61K 47/46 (2013.01); A61K 48/00 (2013.01); A61K 48/005 (2013.01); A61Q 19/008 (2013.01); A61Q 19/06 (2013.01); A61Q 19/08 (2013.01); C12N 15/87 (2013.01); A61B 2018/00452 (2013.01); A61B 2018/1807 (2013.01); A61K 2800/83 (2013.01); A61K 2800/91 (2013.01);
Abstract

The present invention relates in part to nucleic acids, including nucleic acids encoding proteins, therapeutics and cosmetics comprising nucleic acids, methods for delivering nucleic acids to cells, tissues, organs, and patients, methods for inducing cells to express proteins using nucleic acids, methods, kits and devices for transfecting, gene editing, and reprogramming cells, and cells, organisms, therapeutics, and cosmetics produced using these methods, kits, and devices. Methods and products for altering the DNA sequence of a cell are described, as are methods and products for inducing cells to express proteins using synthetic RNA molecules, including cells present in vivo. Therapeutics comprising nucleic acids encoding gene-editing proteins are also described.


Find Patent Forward Citations

Loading…